Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;9(2):153-8.
doi: 10.1016/j.aju.2011.06.008. Epub 2011 Sep 15.

Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy

Affiliations

Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy

Ahmed M Al-Adl et al. Arab J Urol. 2011 Jun.

Abstract

Objective: To investigate the effect of chronic use of sildenafil and intracavernous injection (ICI) with trimix in men not responding to on-demand monotherapy with sildenafil or ICI with prostaglandin-E1 (PGE1).

Patients and methods: The study included 40 patients with erectile dysfunction (ED), with a mean (SD) age of 50.7 (11.3) years and unresponsive to on-demand sildenafil or ICI with PGE1 as monotherapy. They were assessed using the Sexual Health in Men (SHIM)-5 score for ED severity, penile colour Doppler ultrasonography (CDUS) for peak systolic velocity (PSV), end-diastolic velocity (EDV) and resistance index (RI) with an ICI test using 0.25 mL of trimix of papaverine, PGE1 and phentolamine. Testosterone, prolactin and cholesterol levels were assessed. Patients received 25 mg sildenafil daily for 8 weeks, combined with twice weekly ICI with 0.25 mL of trimix. After treatment, the Erection Hardness Score (EHS), penile CDUS with ICI and ED Inventory of Treatment Satisfaction were assessed.

Results: The mean (SD) SHIM-5 score before treatment was 8.3 (0.5) in 15 of the 40 men and 6.3 (0.4) in 25. Penile haemodynamics were normal in five (13%), showed arterial insufficiency in five (13%), venous occlusive disease in 26 (65%) and mixed vascular in four (10%). There was an improved SHIM-5 score in 28 (70%) patients, as shown by their haemodynamic values, duration of erection and EHS with therapy, and 66% satisfaction with treatment. Adverse effects (penile pain, headache, facial flushing, dyspepsia, nasal congestion, dizziness) were reported in 17 patients (43%).

Conclusion: Chronic use of trimix plus daily low-dose sildenafil improved penile haemodynamics in these patients with ED not responding to on-demand phosphodiesterase-5 inhibitors or ICI with PGE1 monotherapy.

Keywords: CDUS, colour Doppler ultrasonography; ED, erectile dysfunction; EDITS, Erectile Dysfunction Inventory of Treatment Satisfaction; EDV, end-diastolic velocity; EH(S), Erection Hardness (Score); Erectile dysfunction; ICI, intracavernous injection; Intracavernous; NO, nitric oxide; PDE, phosphodiesterase; PDE-5I; PGE1; PGE1, prostaglandin E1; PSV, peak systolic velocity; RI, resistance index; SHIM, Sexual Health Inventory for Men; Therapy; VOD, veno-occlusive dysfunction.

PubMed Disclaimer

Similar articles

References

    1. Lue T.F. Erectile dysfunction. N Eng J Med. 2000;342:1802–1813. - PubMed
    1. Lewis R.W., Fugl-Meyer K.S., Bosch R., Fugl-Meyer A.R., Laumann E.O., Lizza E. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1:35–39. - PubMed
    1. Lue T.F., Giuliano F., Montorsi F., Rosen R.C., Andersson K.E., Althof S. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6–23. - PubMed
    1. Mulhall J.P., Goldstein I., Bushmakin A.G., Cappelleri J.C., Hvidsten K. Validation of the erection hardness score. J Sex Med. 2007;4:1626–1634. - PubMed
    1. Mulhall J.P., Althof S.E., Brock G.B., Goldstein I., Jünemann K.P., Kirby M. Erectile dysfunction. Monitoring response to treatment in clinical practice – recommendations of an international study panel. J Sex Med. 2007;4:448–464. - PubMed